with the same period of last year. The income statement in brief is presented as following: DOD BIOTECH PUBLIC COMPANY LIMITED เลขที ่111 หมู่ที ่2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000
13.25 Million or 32.15% compared with the same period of last year. The income statement in brief is presented as following: Unit : Million THB Revenues from Sale 341.59 100.00% 120.13 100.00% 221.46
with the same period of last year. The income statement in brief is presented as following: Unit : Million THB Revenues from Sale 391.51 100.00% 217.59 100.00% 173.92 79.93% Cost of Sales 215.40 55.02
guidelines for investors to understand and monitor future business directions of the Company; 1.1.2 Material changes and developments Give a brief account on the material changes and developments regarding the
the Company; 1.1.2 Material changes and developments Give a brief account on the material changes and developments regarding the controlling power and the nature of business during the preceding year as
Other Information Tender Offer List of management who submitted the changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise
) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31
-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021 (01/01/21 -31/12/21) 2020 (01/01/20 -31/12/20) 2019 (01/01/19 -31/12/19) 2018 (01/01/18
changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version Statement of Comprehensive Income (MB.) 2021
Offer List of management who submitted the changes in securities holding report (59-2) Reports on Acquisition or Disposition of Securities (246-2) Financial Statements (Concise Version) 5/ Full Version